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ABSTRACT
After birth the endocrine pancreas continues its development, a complex process that involves both
the maturation of islet cells and a marked expansion of their numbers. New beta cells are formed both
by duplication of pre-existing cells and by new differentiation (neogenesis) across the first postnatal
weeks, with the result of beta cells of different stages of maturation even after weaning. Improving our
understanding of this period of beta cell expansion could provide valuable therapeutic insights.
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The study of pancreatic development has focused for many
years on the embryonic specification and differentiation of
the various islet cells and the regulation of these processes.
However, development of the postnatal endocrine pancreas is
also a complex process that involves the maturation of islet
cells and marked expansion of their numbers. The work of
Claes Hellerstrom and his colleagues provided a strong basis
for our knowledge of beta cell expansion and the functional
immaturity of fetal/neonatal beta cells. In this paper we will
focus on some concepts that stem from this early work with
regard to beta cell function, mass, and turnover.
Variable age and function within the beta cell
population
It is important to remember that beta cells change during
their lifetime in their capacity for insulin secretion and prolif-
eration. Newborn beta cells have immature secretory function
and a high rate of proliferation (1). With time, their secretory
capacity is enhanced, particularly for glucose-stimulated insu-
lin secretion (GSIS), and their ability to replicate declines.
Then beta cells can progress to senescence with some decline
in secretory function, loss of replication, and susceptibility to
death. A key point is that the age of beta cells is only partially
linked to the age of the person. The slow turnover of beta
cells through life results in beta cells of different ages. Thus, a
young person will have both newborn and older beta cells, as
will an older person; the difference is that the older person
can be expected to have a higher proportion of older cells.
The changing proportions of new and old cells would influ-
ence the overall insulin secretion. This heterogeneity becomes
even more complicated when considering that there are two
ways to create new beta cells. In spite of some past contro-
versy, it has become clear that neogenesis, the generation of
new islets from pancreatic duct cells, takes place throughout
life (2–5). These newly formed cells must go through a
maturation process. However, new beta cells are also gener-
ated by duplication of existing beta cells, and their maturity
is likely dependent of the maturity of the parent cell. Thus,
although not rigorously studied, when immature cells divide,
the daughter cells are expected to be immature, while the
daughter cells of older beta cells are probably mature.
Maturation of insulin secretion
Insulin secretion of immature beta cells is characterized by
weak GSIS, with relatively better responses to nutrients such
as amino acids (1). Not only do immature beta cells respond
poorly to increased glucose levels, but they fail to shut off
insulin secretion efficiently when glucose levels are low (6),
an important feature of mature beta cells, which provides
protection from hypoglycemia.
Exposure of immature beta cells to glucose itself can
enhance maturation. Freinkel and Hellerstrom (7) showed that
fetal rat islets cultured for only 8 days in RPMI 1640 media
with 11mM glucose compared with controls at 2.8mM had
near-adult levels of secretory responses to a challenge of
16.7mM glucose. Additionally, we showed that islets from 2-
day-old rats (P2) treated for 4 days with either adenovirus
expressing the transcription factor MafA or T3 approached the
secretion of adult cells (8,9). Yet Bliss and Sharp (10) showed
with perifused rat islets that glucose-responsive insulin secre-
tion was present by 14 days after birth (P14), but that even at
P21 fully developed glucose responsiveness of the adult had
not yet been reached. Why does it take so long in vivo to
obtain full GSIS? The best explanation seems to be that large
numbers of beta cells are generated late in the first postnatal
month and that their secretory immaturity obscures the
robust secretion from a more mature population of cells.
To understand the molecular basis of this immaturity sev-
eral studies identified single genes with low expression
thought to play a role in the maturation process. To examine
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a larger number of genes we performed microarray analysis
of laser-captured beta cells from P1 rats compared to those
from adults and found that many genes were differentially
expressed, including many that were important components
of specialized NADH mitochondrial shuttles that are unique
to beta cells (11). Some of these genes with low expression
at P1 (e.g. pyruvate carboxylase, maleic enzyme1, maleate
dehydrogenase, glutamate oxaloacetate transaminase, and
glycerol phosphate dehydrogenase 2) only reached adult lev-
els of mRNA by P28, with sharp increases only after P21. This
suggests that important mitochondrial shuttles are undevel-
oped, most notably the glycerol–phosphate, malate–aspartate,
pyruvate–citrate, and pyruvate–malate shuttles. Thus, the
metabolic specialization found in adult beta cells for amplify-
ing the ATP derived from glycolysis is deficient in neonatal
beta cells. Other key beta cell genes had low expression and
only reach adult levels by P28; these include insulin, glut 2,
PCSK1, and GLP1R (8).
Changes in beta cell mass during first postnatal
month
The first postnatal month is a time of many changes for the
endocrine pancreas (Figure 1) as documented by a longitu-
dinal study of the determinants of the beta cell mass over
the first postnatal month (P2, 9, 13, 17, 29, 24, and 31) in
Sprague Dawley rats (12). Replication was highest perinatally,
with a gradual decline over the month. At P2, 6 h BrdU
incorporation labeled 4.7% 6 0.3% of beta cells; by P13 it
had fallen to 2.2% 6 0.5% and then to 1.8% 6 0.2% by P31.
This is still greater than the lower level seen in 2–3-month-
old adults (0.22% 6 0.06%). Similarly, throughout this month
the frequency of apoptotic beta cells was higher than in the
adult (0.5%), being 1.54% 6 0.22% at P2, P9, and again after
20 days. However, there is a very interesting increase of
apoptosis (3.64% 6 0.45%) between P13 and P17 of age,
which precedes weaning. This wave of apoptosis has
attracted the interest of immunologists trying to understand
the pathogenesis of type 1 diabetes because of the release of
antigens. In spite of this increased apoptosis, beta cell mass
was stable from 2 to 20 days (range: 0.916 0.2mg to
1.336 0.23mg) and increased thereafter. To maintain the
constant beta cell mass in the face of decreased replication
and increased incidence of apoptosis in the beta cells a wave
of neogenesis of beta cells is strongly suggested. We esti-
mated the cell number based on these data and determined
that replication could only account for 50%–70% of the beta
cells present at P31 (13).
Evidence of neogenesis within the first postnatal
month
Most evidence for neogenesis has been correlative, being
indicated by insulin-positive cells embedded in ducts, co-
staining for cytokeratin and insulin, or by increased presence
of small clusters of islet cells in situations of increased beta
cell mass such as pregnancy. More convincing support for the
presence of neogenesis can be provided by lineage tracing in
mice. Data from three of our experimental models provide
further support for the estimate that neogenesis accounts for
30%–50% of the new beta cells found during the first postna-
tal month, with further support provided by other groups.
Transient expression of MMP2, marker of newly
formed beta cells
Using gene expression data from laser-captured microdis-
sected beta cells of P1 rats, we searched for markers of newly
formed beta cells using immunostaining (14). One of these
markers, MMP2 protein, had strong staining in beta cells at
embryonic age E20 that was even more intense at birth. After
48 hours, MMP2 expression started to decrease and had dis-
appeared by P7. However, at P17, a time predicted to have
more neogenesis, 51% of the islets (545/1,074; from 4 rats)
had MMP2 co-staining with insulin, and the pattern was lobu-
lar (Toschi et al. unpublished data). This expression was transi-
ent, with 16% at P14 (127/798 islets; n¼ 2) of the islets
having MMP2 immunostaining, 17% (198/1159; n¼ 4) at P20,
and only 1% (10/1,096; from 4 rats) at P24. Essentially no
positive staining was found in adult rats.
Lineage tracing using carbonic anhydrase II
Cre:ROSA26-LSLbGal mice
Carbonic anhydrase II (CAII) only starts to be expressed in
pancreatic ducts at the very end of gestation and has been
considered a duct-specific marker within the pancreas (15).
Using Cre-lox lineage tracing driven by the CAII promoter, we
found that at 4 weeks after birth both islets and acini were
marked as having been formed from cells that once
expressed CAII; 38% of the islets were marked (17% of all
insulin-positive cells) as well as a number of acinar cells, with
some lobes being strongly marked and others not (16).
Duct-specific deletion of Pdx1
Using these CAIICre mice crossed with Pdx1floxE2 mice (17) so
that Pdx1 expression would be specifically deleted from ducts
Figure 1. Schematic drawing of the dynamic changes in the determinants of
beta cell growth from the first postnatal month into adulthood. This diagram
(drawn not to scale) is based on the data in Scaglia et al. (12). Extending past
this same period is the process of functional maturation of the beta cells.
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only starting around birth, we found Pdx1 is not necessary for
formation of new beta cells from postnatal pancreatic ducts;
however, it is required for these newly formed beta cells to
become fully mature (18). What was striking was that there
were three types of islets in each section of adult pancreas:
30% with normal strong PDX1 expression, 20% with little to
no PDX1 expression, and 50% mixed insulin-positive cells
with and without PDX1 staining. We interpret the group with
strong PDX1 as those islets formed before birth, and those
without PDX1 as being formed by neogenesis after birth. The
group with mixed expression suggests a coalescence of newly
formed PDX1 beta cells with islets or clusters of beta cells
formed before birth. Alternatively, these cells could have
arisen from the intra-islet ducts shown in a recent study from
the Gittes lab (3). The PDX1-deficient beta cells accounted for
32% of all beta cells in 10-week-old mice; the lineage of these
cells from ducts was verified by their expression of the
recombination reporter eYFP.
Other studies finding increased islet number in the early
postnatal period
In addition to our studies, several other groups have provided
documentation of a substantially increased number of islets
or insulin-positive cell clusters occurring from birth to 2
months of age. Chintinne et al. concluded that about 30,000
beta cell clusters of less than 50 lm formed between P2 and
10 weeks in Wistar rats (19). In mice Peng et al. (20) reported
about 50 islets per pancreas at 1 week but 900 at 2 months,
after which time it was stable. With MIP:GFP mice Jo et al.
(21) modeled that there was fission of larger islets after birth
and that within the first 3 weeks postnatally 800 new islets
were formed: 300 by fission and 500 by neogenesis. There is
the caveat for such enumeration of islets that small clusters
initially below the limit of detection may enlarge by replica-
tion and be erroneously counted as being newly formed by
neogenesis. Realizing this, the above-mentioned studies had
lower detection limits of one (19), two (20), or four (21) cells.
Neglected issue in postnatal pancreas development:
rapid pancreatic growth from 2 to 4 weeks of age
In the first postnatal month there is marked growth of the
mouse or rat accompanied by even more growth of the pan-
creas. Between P2 and P9 in rats both the body weight and
the pancreatic weight have 1.8-fold increases, but between
P13 and P31 the body weight increases 2.6-fold whereas the
pancreatic weights increase 5-fold (12). A similar divergence
in mice is seen with a 2.6-fold increase in body weight and
3.7-fold in pancreatic weight from 2 to 4 weeks of age (18).
In the first week there is extensive growth of the exocrine
pancreas, with formation of new acini such that the loose
appearance of the sectioned pancreas seen at birth is lost as
the pancreas develops the packed appearance as seen in the
adult. The subsequent growth cannot be accounted for by
enlarged acini from replication but rather as extensions of the
pre-existing lobes of pancreas as well as formation of new
lobes by proliferation of the ducts accompanied by their
subsequent differentiation into islets and acini (Figure 2).
With extension of the main ducts and branching formation of
new lobes, as we saw in the regeneration model of partial
pancreatectomy (22,23), the distribution of islets eventually is
similar in lobes that developed at different times, each with
larger islets closer to the main ducts and smaller islets
towards the periphery. The marking of lobes of pancreas in
the lineage-tracing experiments (above) with CAIIcre:ROSA26
LSL mice supports the concept of new lobe formation within
the first neonatal month.
The time between 2 and 4 weeks of age is one of chang-
ing diet and systemic hormonal changes as rats start adding
chow to their milk diet (24). The rapid growth of pancreas
between 2 and 4 weeks and the estimates of new islets and
of newly formed beta cells support the concept of a substan-
tial wave of neogenesis occurring just before weaning. While
it is unclear how long the maturation process normally takes
for individual beta cells, glucose-responsive insulin secretion
was seen by P14 (10) and became more robust by P21 but
still failed to reach the even greater secretory responses seen
in adults (2–3 months old). Our premise is that the continued
presence of immature beta cells even as late as P21 accounts
for this difference.
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